Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05270057
Title Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies (LONCA)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications

Burkitt lymphoma

plasmablastic lymphoma

diffuse large B-cell lymphoma

primary mediastinal B-cell lymphoma

B-cell lymphoma

Therapies

Cyclophosphamide + Doxorubicin + Etoposide + Loncastuximab tesirine-lpyl + Prednisone + Rituximab + Vincristine Sulfate

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.